Nomination Committee of Surgical Science Sweden AB (publ)

The following members have been appointed to Surgical Sciences' Nomination Committee for the 2023 Annual General Meeting:

Åsa Hedin, appointed by Marknadspotential AB
Celia Grip, appointed by Swedbank Robur Fonder
Anna Sundberg, appointed by Handelsbanken Fonder
Roland Bengtsson, Chairman of the Board

The appointments have been made in accordance with the instructions regarding principles for the appointment of the company’s Nomination Committee established at the Annual General Meeting of Surgical Science on May 6, 2020. The shareholders that have appointed the members of the Nomination Committee represented in aggregate just above 32 percent of all shares in the company as of September 30, 2022.

The Nomination Committee shall prepare and submit proposals to the Annual General Meeting regarding: (i) election of Chairman of the Meeting, (ii) election of board members, (iii) election of Chairman of the Board, (iv) resolution on board remuneration with the division between the chairman and other members of the board, (v) resolution on remuneration for the members of the Remuneration and Audit Committee (if applicable), (vi) election of auditors, (vii) resolution on remuneration of auditors, and (viii) to the extent deemed necessary, resolution on amendments in current rules for the Nomination Committee.

The Annual General Meeting of Surgical Science Sweden AB (publ) will be held on Wednesday, May 17, 2023 in Gothenburg. Shareholders who wish to submit proposals to the Nomination Committee are welcome to do so in due time before the 2023 Annual General Meeting so that the Nomination Committee has time to consider the proposal. Proposals may be sent to Surgical Science Sweden AB (publ), Att: Nomination Committee, Drakegatan 7A, 412 50 Gothenburg, Sweden.

Gothenburg, Sweden, October 27, 2022
Surgical Science Sweden AB (publ)

The press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the clinical environment. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 230 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Stockholm, Sweden, as well as in Tel Aviv, Israel and Seattle, US. Through sales offices in the US, France and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Phone: +46 8-463 83 00; E-mail: certifiedadviser@penser.se).

Nomination Committee of Surgical Science Sweden AB (publ)